Physicians should thus remain vigilant to CHF symptoms in patients taking these drugs

Weight loss improves glycemic control, lipid profiles, and blood pressure in patients with type 2 diabetes.

An international study indicates acarbose could be used to delay the development of Type II diabetes in patients with impaired glucose tolerance.

Growth hormone and metformin may be effective treatments for metabolic syndrome.

Microvascular disease may predict subsequent development of type 2 diabetes mellitus

In Kuwait, research found that “the percentage of diabetic individuals who were in the highest 20% of CRP values were four times more likely to be suffering from cardiovascular disease compared to those who were in the lowest 20% of CRP,” according to Nabila Abdella, MB, CHP, FRCP, Professor of …

Yes, it can, that from a large prospective long-term study.

Effective treatment of elevated post-prandial glucose levels in hyperglycemic patients may reduce cardiovascular disease and mortality associated with type 2 diabetes.

Current use of OCs was associated with lower glucose levels in a racially diverse sample of young women

Replacement of amylin with pramlintide reduces excessive glucose fluctuations in patients with type 1 diabetes.